Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase A02.008: murine leukemia virus-type retropepsin

Summary Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Inhibitors Pharma

(Topics flags: S Structure, P Specificity, I Inhibitor, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2019
  1. Hakata,Y., Li,J., Fujino,T., Tanaka,Y., Shimizu,R. and Miyazawa,M.
    Mouse APOBEC3 interferes with autocatalytic cleavage of murine leukemia virus Pr180gag-pol precursor and inhibits Pr65gag processing
    PLoS Pathog (2019) 15, e1008173-e1008173. PubMed  Europe PubMed DOI
    2. 2012
  2. Furukawa,A., Okamura,H., Morishita,R., Matsunaga,S., Kobayashi,N., Ikegami,T., Kodaki,T., Takaori-Kondo,A., Ryo,A., Nagata,T. and Katahira,M.
    NMR study of xenotropic murine leukemia virus-related virus protease in a complex with amprenavir
    Biochem Biophys Res Commun (2012) 425, 284-289. PubMed  Europe PubMed DOI  I
  3. Loving,R., Wu,S.R., Sjoberg,M., Lindqvist,B. and Garoff,H.
    Maturation cleavage of the murine leukemia virus Env precursor separates the transmembrane subunits to prime it for receptor triggering
    Proc Natl Acad Sci U S A (2012) 109, 7735-7740. PubMed  Europe PubMed DOI  I
  4. Matsunaga,S., Sawasaki,T., Ode,H., Morishita,R., Furukawa,A., Sakuma,R., Sugiura,W., Sato,H., Katahira,M., Takaori-Kondo,A., Yamamoto,N. and Ryo,A.
    Molecular and enzymatic characterization of XMRV protease by a cell-free proteolytic analysis
    J Proteomics (2012) 75, 4863-4873. PubMed  Europe PubMed DOI
  5. Matuz,K., Motyan,J., Li,M., Wlodawer,A. and Tozser,J.
    Inhibition of XMRV and HIV-1 proteases by pepstatin A and acetyl-pepstatin
    FEBS J (2012) 279, 3276-3286. PubMed  Europe PubMed DOI  I
  6. Menendez-Arias,L., Tozser,J. and Oroszlan,S.
    Moloney murine leukemia virus retropepsin
    [ISSN:978-0-12-407744-7] (2012) 3, 226-230. DOI
    7. 2011
  7. Li,M., Dimaio,F., Zhou,D., Gustchina,A., Lubkowski,J., Dauter,Z., Baker,D. and Wlodawer,A.
    Crystal structure of XMRV protease differs from the structures of other retropepsins
    Nat Struct Mol Biol (2011) 18, 227-229. PubMed  Europe PubMed DOI  S
  8. Li,M., Gustchina,A., Matuz,K., Tozser,J., Namwong,S., Goldfarb,N.E., Dunn,B.M. and Wlodawer,A.
    Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease
    FEBS J (2011) 278, 4413-4424. PubMed  Europe PubMed DOI  S  I
    9. 2008
  9. Eizert,H., Bander,P., Bagossi,P., Sperka,T., Miklossy,G., Boross,P., Weber,I.T. and Tozser,J.
    Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site
    J Virol (2008) 82, 10111-10117. PubMed  Europe PubMed DOI  PMC  EPMC  P
  10. Vu,H.N., Ramsey,J.D. and Pack,D.W.
    Engineering of a stable retroviral gene delivery vector by directed evolution
    Mol Ther (2008) 16, 308-314. PubMed  Europe PubMed DOI
    11. 2006
  11. Feher,A., Boross,P., Sperka,T., Miklossy,G., Kadas,J., Bagossi,P., Oroszlan,S., Weber,I.T. and Tozser,J.
    Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease
    J Gen Virol (2006) 87, 1321-1330. PubMed  Europe PubMed DOI
    12. 2005
  12. Bagossi,P., Sperka,T., Feher,A., Kadas,J., Zahuczky,G., Miklossy,G., Boross,P. and Tozser,J.
    Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites
    J Virol (2005) 79, 4213-4218. PubMed  Europe PubMed DOI  PMC  EPMC  P
    13. 2004
  13. Feher,A., Boross,P., Sperka,T., Oroszlan,S. and Tozser,J.
    Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli
    Protein Expr Purif (2004) 35, 62-68. PubMed  Europe PubMed DOI  E
  14. Menendez-Arias,L., Tozser,J. and Oroszlan,S.
    Moloney murine leukemia virus retropepsin
    [ISSN:0-12-079610-4] (2004) 2, 176-178.  V
  15. Oshima,M., Muriaux,D., Mirro,J., Nagashima,K., Dryden,K., Yeager,M. and Rein,A.
    Effects of blocking individual maturation cleavages in murine leukemia virus gag
    J Virol (2004) 78, 1411-1420. PubMed  Europe PubMed DOI  PMC  EPMC
    16. 1999
  16. Boross,P., Bagossi,P., Copeland,T.D., Oroszlan,S., Louis,J.M. and Tozser,J.
    Effect of substrate residues on the P2 ' preference of retroviral proteinases
    Eur J Biochem (1999) 264, 921-929. PubMed  Europe PubMed DOI
    17. 1998
  17. Cannon,K., Qin,L., Schumann,G. and Boeke,J.D.
    Moloney murine leukemia virus protease expressed in bacteria is enzymatically active
    Arch Virol (1998) 143, 381-388. PubMed  Europe PubMed DOI
    18. 1996
  18. Tristem,M., Kabat,P., Lieberman,L., Linde,S., Karpas,A. and Hill,F.
    Characterization of a novel murine leukemia virus-related subgroup within mammals
    J Virol (1996) 70, 8241-8246. PubMed  Europe PubMed  PMC  EPMC
    19. 1995
  19. Menendez-Arias,L., Weber,I.T. and Oroszlan,S.
    Mutational analysis of the substrate binding pocket of murine leukemia virus protease and comparison with human immunodeficiency virus proteases
    J Biol Chem (1995) 270, 29162-29168. PubMed  Europe PubMed DOI
    20. 1994
  20. Menendez-Arias,L., Weber,I.T., Soss,J., Harrison,R.W., Gotte,D. and Oroszlan,S.
    Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease
    J Biol Chem (1994) 269, 16795-16801. PubMed  Europe PubMed
    21. 1993
  21. Black,P.L., Downs,M.B., Lewis,M.G., Ussery,M.A., Dreyer,G.B., Petteway,S.R., Jr. and Lambert,D.M.
    Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue culture
    Antimicrobial Agents Chemother (1993) 37, 71-77. PubMed  Europe PubMed  PMC  EPMC
  22. Menendez-Arias,L., Gotte,D. and Oroszlan,S.
    Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme
    Virology (1993) 196, 557-563. PubMed  Europe PubMed DOI
    23. 1991
  23. Pettit,S.C., Simsic,J., Loeb,D.D., Everitt,L., Hutchison,C.A., III and Swanstrom,R.
    Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid
    J Biol Chem (1991) 266, 14539-14547. PubMed  Europe PubMed
    24. 1987
  24. [YEAR:15-10-1987]Katoh,I., Yasunaga,T., Ikawa,Y. and Yoshinaka,Y.
    Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor
    Nature (15-10-1987) 329, 654-656. PubMed  Europe PubMed DOI  I
    25. 1985
  25. Katoh,I., Yoshinaka,Y., Rein,A., Shibuya,M., Odaka,T. and Oroszlan,S.
    Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity
    Virology (1985) 145, 280-292. PubMed  Europe PubMed
  26. Toh,H., Kikuno,R., Hayashida,H., Miyata,T., Kugimiya,W., Inouye,S., Yuki,S. and Saigo,K.
    Close structural resemblance between putative polymerase of a Drosophila transposable genetic element 17.6 and pol gene product of moloney murine leukaemia virus
    EMBO J (1985) 4, 1267-1272. PubMed  Europe PubMed  PMC  EPMC
  27. Yoshinaka,Y., Katoh,I., Copeland,T.D. and Oroszlan,S.
    Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon
    Proc Natl Acad Sci U S A (1985) 82, 1618-1622. PubMed  Europe PubMed  PMC  EPMC
    28. 1977
  28. Yoshinaka,Y. and Luftig,R.B.
    Properties of a P70 proteolytic factor of murine leukemia viruses
    Cell (1977) 12, 709-719. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2026 EBI
Terms of use